Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

China flag China · Delayed Price · Currency is CNY
12.54
-0.04 (-0.32%)
Jun 13, 2025, 3:04 PM CST
30.62%
Market Cap 16.81B
Revenue (ttm) 5.28B
Net Income (ttm) 648.29M
Shares Out 1.47B
EPS (ttm) 0.44
PE Ratio 28.39
Forward PE 24.00
Dividend 0.25 (1.99%)
Ex-Dividend Date n/a
Volume 9,724,440
Average Volume 5,877,252
Open 12.49
Previous Close 12.58
Day's Range 12.42 - 12.89
52-Week Range 8.10 - 12.89
Beta 0.37
RSI 70.07
Earnings Date Aug 29, 2025

About SHE:002399

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates through four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. The company’s pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium ... [Read more]

Sector Healthcare
Founded 1998
Employees 1,926
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002399
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.